Immune Cell Vector Kit for Modular Multi-Transgene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing vector systems, such as retroviral vectors, face limitations in packaging capacity and efficiency, leading to mixed populations of cells with varying transgene expression due to incomplete transduction, necessitating the need for alternative systems capable of expressing multiple transgenes reliably.
Innovation Solution
A kit of vectors is employed, where a first vector expresses a transcription factor, and subsequent vectors are dependent on this factor for expression, allowing modular and flexible transgene expression, with a marker gene ensuring successful transduction of all vectors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If multiple genes are expressed from a single retroviral vector, then gene expression capability is improved, but vector packaging size limit is exceeded
Solution Approach 1:
The patent divides the expression of multiple transgenes across separate vector cassettes. Each cassette contains one or more transgenes and can be independently packaged and transduced into the cell. This segmentation allows each vector to remain within packaging size limits while collectively expressing multiple genes.
Solution Approach 2:
The patent combines multiple vector cassettes into a single cell through co-transduction. Multiple independently packaged vectors are introduced into the cell simultaneously, and their expression cassettes are integrated into the cell genome, achieving multi-gene expression without requiring a single large vector.
2Quantity of substance
If multiple vectors are transduced into a cell, then number of transgenes is improved, but transduction efficiency decreases
Solution Approach 1:
The patent uses a selection marker gene as an intermediary to identify and select cells that have been successfully transduced with all required vectors. The selection marker allows for easy identification of double-transduced cells, enabling researchers to select only the cells with the desired multi-gene expression profile.
Solution Approach 2:
The patent incorporates selection markers that provide feedback about transduction status. By expressing detectable markers (such as fluorescent proteins or antibiotic resistance genes), the system enables monitoring and selection of cells with successful vector integration, allowing optimization of the transduction process.
3Ease of operation
If a selection marker is added to the vector, then cell selection capability is improved, but vector complexity increases
Solution Approach 1:
The selection marker gene serves multiple functions: it enables identification of transduced cells, facilitates selection of cells with desired transgenes, and can be used to monitor transduction efficiency. This multi-functionality justifies the addition of the marker despite the increased vector complexity.
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The present invention provides a kit of vectors for transducing an immune cell with multiple transgenes comprising: (i) a first vector which comprises a first transgene and a nucleotide sequence encoding a transcription factor and; and (ii) a second vector which comprises a second transgene wherein expression of the second transgene within a host cell is dependent upon expression of the transcription factor.